Document is current
Any future updates will be listed below
-
Authors
Sautkin, Yaroslaw
Weinreich, Juergen
Reymond, Marc André
-
Funding
Funding for this research was provided by:
Capnopharm GmbH, Tübingen, Germany
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 25 May 2024
Accepted: 5 August 2024
First Online: 19 August 2024
Declarations
:
: Dr. Yaroslaw Sautkin is a consultant at CapnoPharm GmbH, Tübingen, Germany. Dr. Juergen Weinreich has no conflicts of interest or financial ties to disclose. Prof. Marc André Reymond has an equity interest in Capnopharm GmbH, Tuebingen, Germany and holds granted patents on Capnopen® and multi-nozzle nebulisers for PIPAC.
